MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.

about

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.

Item

http://www.wikidata.org/entity/Q51286673

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.

@en

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.

@nl

type

Item

label

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.

@en

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.

@nl

prefLabel

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.

@en

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.

@nl

P1476

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.

@en

P2093

Hiroshi Imai

http://www.w3.org/2001/XMLSchema#string

Isao Tawara

http://www.w3.org/2001/XMLSchema#string

Kana Miyazaki

http://www.w3.org/2001/XMLSchema#string

Kyoko Kobayashi

http://www.w3.org/2001/XMLSchema#string

Kyosuke Tanaka

http://www.w3.org/2001/XMLSchema#string

Naoyuki Katayama

http://www.w3.org/2001/XMLSchema#string

Ryoichi Ono

http://www.w3.org/2001/XMLSchema#string

Tetsuya Nosaka

http://www.w3.org/2001/XMLSchema#string

Toshifumi Takeuchi

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Oncogenically active MYD88 mutations in human lymphoma

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival.

De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.

Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.

De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.

Gene expression profiling of diffuse large B-cell lymphoma supervised by CD21 expression.

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.

High prevalence of the MYD88 mutation in testicular lymphoma: Immunohistochemical and genetic analyses.

P304

1166-1173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.30404

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Motoko Yamaguchi

P577

2016-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27915469

http://www.w3.org/2001/XMLSchema#string